NCT04156984View on ClinicalTrials.gov

Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 7, 2021

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions
Ulcerative Colitis
Interventions
DRUG

Golimumab Prefilled Syringe

See arm description

Trial Locations (4)

1000

University Medical Centre Ljubljana, Department of Gastroenterology, Ljubljana

2000

University Medical Centre Maribor, Department of Gastoenterology, Maribor

3000

General hospital Celje, Department of Gastoenterology, Celje

6310

General hospital Izola, Department of Internal medicine, Izola

All Listed Sponsors
lead

David Drobne

OTHER

NCT04156984 - Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis | Biotech Hunter | Biotech Hunter